White Papers: In Depth Research

• Special Report: The Time is Right for Virtualization

  Posted: May 03, 2017

  Author: pepperl+fuchs

  In this special report, we explore how virtualization can provide significant advantages for deploying process control systems at pharmaceutical plants.

• Special Report: Addressing Process Contamination Risks

  Posted: Apr 24, 2017

  Author: WIKA

  The high risk involved with biopharmaceuticals means there are high demands placed on the hygienic design of bioprocessing equipment. Instrument connections on equipment -- commonly used to position measurement instruments in the process flow for accurate

• 2016 Liquid Dose Trends

  Posted: Aug 26, 2016

  Parenteral drugs are taking a strong position alongside the more established oral solid dose forms and are quickly coming into their own.

• eBook: Biopharmaceutical Technical Resource Guide

  Posted: Dec 20, 2015

  Biopharma R&D spending by PhRMA members grew from $2 billion in 1980 to some $51.6 billion in 2013. While no one’s crystal ball can exactly predict where the industry is headed, it is clear that Biopharma is soaring.